About
About IDT Australia Limited
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers integrated services, including development, analytical testing, clinical packaging; and microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides formulation and manufacture of speciality orals (medicinal cannabis) and advanced therapies; psychedelics and medicinal cannabis; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
Visit company website
5 years, 5 months ago
IDT Australia Limited is currently in a long term uptrend where the price is trading 25.5% above its 200 day moving average.
From a valuation standpoint, the stock is 96.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.
IDT Australia Limited's total revenue sank by 19.5% to $6M since the same quarter in the previous year.
Its net income has increased by 195.0% to $1M since the same quarter in the previous year.
Finally, its free cash flow grew by 107.9% to $118K since the same quarter in the previous year.
Based on the above factors, IDT Australia Limited gets an overall score of 4/5.